Showing results (121-130 of 243) with videos related to
Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)David S Moura, Jesus Lopez-Marti, Hussein Tawbi, et al.Cancer Chemotherapy and Pharmacology|March 7, 2012
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patientsDavid A Reardon, Charles A Conrad, Timothy Cloughesy, et al.Carcinogenesis|July 9, 2010
Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma riskYanhong Liu, Sanjay Shete, Li-E Wang, et al.Biorxiv : the Preprint Server for Biology|September 29, 2025
Pathologist-interpretable breast cancer subtyping and stratification from AI-inferred nuclear featuresRanjan Kumar Barman, Saugato Rahman Dhruba, Danh-Tai Hoang, et al.The American Journal of Pathology|January 28, 2003
CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophagesCorinna Trebst, Susan M Staugaitis, Pia Kivisäkk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variationLuo Wang, Qingyi Wei, Li-E Wang, et al.Oncotarget|May 10, 2014
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesKonrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.Acta Neuropathologica Communications|January 30, 2024
Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumorFrank M Mezzacappa, Frankie K Smith, Weiwei Zhang, et al.Pageof 25